Deng Tianqin, Li Xuemei, Yao Bing
Center of Reproductive Medicine, Nanjing Jinling Hospital, The First School of Clinical Medicine, Southern Medical University (General Hospital of Eastern Military Region), Nanjing, China.
Reproductive Medical Center, Affiliated Shenzhen Maternity & Child Healthcare Hospital, Southern Medical University, Shenzhen, China.
Transl Androl Urol. 2023 Jul 31;12(7):1101-1114. doi: 10.21037/tau-23-14. Epub 2023 Jul 28.
In the pathological study of necrozoospermia-a form of sperm mortality-the underlying metabolic mechanism remains unclear. Thus, the aim of this study was to characterize metabolic alterations in the seminal plasma of necrozoospermic patients and to provide insights into the etiology of the disease.
Seminal plasma samples were collected from patients diagnosed with necrozoospermia (n=28) as well as normozoospermia (n=37). The samples were analyzed using nontargeted metabolomics based on liquid chromatography-mass spectrometry (LC-MS). The raw data were subjected to multivariate analysis to identify metabolites correlated with necrozoospermia. Differential metabolites were subjected to pathway analysis using MetaboAnalyst.
The results of the metabolomic analysis showed that there were 194 differential metabolites between the two groups; 129 metabolites were upregulated and 65 metabolites were downregulated. Among the differential metabolites, the top ten differential metabolites were choline, benzaldehyde, pyrazinamide, 5-aminoimidazole-4-carboxamide, and dihydrothymine. The following differential metabolite pathways were identified, and the top five metabolite pathways were arachidonic acid metabolism, steroid hormone biosynthesis, alanine aspartate and glutamate metabolism, bile secretion, and prostate cancer.
The elevation of choline and 2-hydroxyglutarate levels in seminal plasma was an important finding, and the results also indicate that abnormalities in arachidonic acid metabolism and glutamate metabolism were an underlying pathological mechanism of necrozoospermia.
在死精症(一种精子死亡形式)的病理研究中,潜在的代谢机制仍不清楚。因此,本研究的目的是表征死精症患者精液中代谢变化,并深入了解该疾病的病因。
从被诊断为死精症的患者(n = 28)以及正常精子症患者(n = 37)中收集精液样本。使用基于液相色谱 - 质谱联用(LC - MS)的非靶向代谢组学对样本进行分析。对原始数据进行多变量分析以鉴定与死精症相关的代谢物。使用MetaboAnalyst对差异代谢物进行通路分析。
代谢组学分析结果显示,两组之间有194种差异代谢物;129种代谢物上调,65种代谢物下调。在差异代谢物中,前十大差异代谢物为胆碱、苯甲醛、吡嗪酰胺、5 - 氨基咪唑 - 4 - 甲酰胺和二氢胸腺嘧啶。鉴定出以下差异代谢物通路,前五大代谢物通路为花生四烯酸代谢、类固醇激素生物合成、丙氨酸天冬氨酸和谷氨酸代谢、胆汁分泌以及前列腺癌。
精液中胆碱和2 - 羟基戊二酸水平升高是一项重要发现,结果还表明花生四烯酸代谢和谷氨酸代谢异常是死精症的潜在病理机制。